Company page

Enliven Therapeutics, Inc.

Enliven Therapeutics, Inc. (Ticker: ELVN) is a public company based in the United States, focusing on innovative therapeutic solutions. With a market capitalization of approximately $3.22 billion, Enliven is positioned in the healthcare sector, aiming to address unmet medical needs. The company's commitment to advancing therapeutic options reflects its dedication to improving patient outcomes.